A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BMMs / bone marrow-derived macrophages

[Related PubMed/MEDLINE]
Total Number of Papers: 372
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BMMs  (>> Co-occurring Abbreviation)
Long Form:   bone marrow-derived macrophages
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Activation of ASC Inflammasome Driven by Toll-Like Receptor 4 Contributes to Host Immunity against Rickettsial Infection. IL-1beta, LPS, TLR4
2020 An antibody to Notch3 reverses the skeletal phenotype of lateral meningocele syndrome in male mice. LMS, NRR, OB
2020 An Inducible Cre-lox System to Analyze the Role of LLO in Listeria monocytogenes Pathogenesis. hly, LLO
2020 Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo. LPS
2020 Assessing the effects of cyclosporine A on the osteoblastogenesis, osteoclastogenesis, and angiogenesis mediated by human periodontal ligament stem cells. ALP, CsA, ERK, hPDLSCs, HUVECs, PCR
2020 Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex. IONPs, IONPs, MRI, RANKL, TRAP
2020 Both HuR and miR-29s regulate expression of CB1 involved in infiltration of bone marrow monocyte/macrophage in chronic liver injury. CB1, HuR, mRNA
2020 Colorectal cancer cells promote osteoclastogenesis and bone destruction through regulating EGF/ERK/CCL3 pathway. CRC
2020 Connective tissue growth factor (CTGF) regulates the fusion of osteoclast precursors by inhibiting Bcl6 in periodontitis. BCL6, CTGF, DC-STAMP, NFATc1
10  2020 Curcumin inhibits the migration of osteoclast precursors and osteoclastogenesis by repressing CCL3 production. OCPs
11  2020 Curcumin-activated autophagy plays a negative role in its anti-osteoclastogenic effect. OCPs
12  2020 Effect of Danshen on TLR2-triggered inflammation in macrophages. DSE, DSS, ELISA, ERK, IL, JNK, MAPK, PA, RT-qPCR, TLR, TNF
13  2020 Farnesoid X Receptor Activation Protects Liver From Ischemia/Reperfusion Injury by Up-Regulating Small Heterodimer Partner in Kupffer Cells. CD, FXR, IRIs, KCs, SHP
14  2020 Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/beta-catenin signalling pathway and prevents ovariectomy-induced bone loss. ALP, BMD, BMSCs, Foxf1, PMOP, qRT-PCR, siRNA
15  2020 Gasdermin D-independent release of interleukin-1beta by living macrophages in response to mycoplasmal lipoproteins and lipopeptides. GSDMD, IL-1beta, MpLP, MsLP, NLRP3
16  2020 Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis. RANKL, SREs, TRAP
17  2020 GSH attenuates RANKL-induced osteoclast formation in vitro and LPS-induced bone loss in vivo. NFATc1, OSCAR, RANKL, ROS, TRAP
18  2020 Inhibition of nuclear factor kappa B as a mechanism of Danshensu during Toll-like receptor 2-triggered inflammation in macrophages. Ccr7, CXCL9, DEGs, DSS, ELISA, IFN-gamma, IL-12, IL-6, LTF, MAPKs, NF-kappaB, PPI, RT-qPCR, TF, TLR2
19  2020 Investigation of resident and recruited macrophages following disc injury in mice. GFP, IVDs
20  2020 Lipopolysaccharide promotes Drp1-dependent mitochondrial fission and associated inflammatory responses in macrophages. Drp1, LPS, MyD88, TLR4
21  2020 Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling. ALP, JNK, LPS, MA, NFATc1, RANKL, TRAP
22  2020 Mice Lacking the Purinergic Receptor P2X5 Exhibit Defective Inflammasome Activation and Early Susceptibility to Listeria monocytogenes. ---
23  2020 miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss. IL-1, miR-128, NF-kappaB, PMOP, SIRT1, TNF-alpha
24  2020 miR-506-3p alleviates uncontrolled osteoclastogenesis via repression of RANKL/NFATc1 signaling pathway. NFATc1, RANKL
25  2020 N16 suppresses RANKL-mediated osteoclatogenesis by down-regulating RANK expression. ---
26  2020 Osteoclastic miR-301-b knockout reduces ovariectomy (OVX)-induced bone loss by regulating CYDR/NF-kappaB signaling pathway. CYLD, IL-1beta, miRNAs, NF-kappaB, NFATC1, PMOP, TNF-alpha
27  2020 Quantitative Proteome Responses to Oncolytic Reovirus in GM-CSF- and M-CSF-Differentiated Bone Marrow-Derived Cells. GM-CSF, M-CSF, OVs, TMT
28  2020 RNF90 negatively regulates cellular antiviral responses by targeting MITA for degradation. BMDCs, MEFs, RNF
29  2020 Spi-C positively regulates RANKL-mediated osteoclast differentiation and function. IkappaBalpha, MAPK, RANK, RANKL, TRAP
30  2020 Substance P participates in periodontitis by upregulating HIF-1alpha and RANKL/OPG ratio. HIF-1alpha, LPS, OPG, RANKL
31  2020 Substrate stiffness modulates bone marrow-derived macrophage polarization through NF-kappaB signaling pathway. ECM, ROS
32  2020 TLR2 and endosomal TLR-mediated secretion of IL-10 and immune suppression in response to phagosome-confined Listeria monocytogenes. ---
33  2020 Ubiquitin-specific protease 34 inhibits osteoclast differentiation by regulating NF-kappaB signaling. USP34
34  2020 [Experimental study on the inhibition of Formononetin on the differentiation of osteoclasts induced by RANKL]. FO
35  2019 Anti-Osteoporotic and Anti-Adipogenic Effects of the Water Extract of Drynaria roosii Nakaike in Ovariectomized Mice Fed a High-Fat Diet. HFD, IL, RANKL, WDR
36  2019 Artemisinin inhibits breast cancer-induced osteolysis by inhibiting osteoclast formation and breast cancer cell proliferation. ART
37  2019 Asperosaponin VI protects against bone destructions in collagen induced arthritis by inhibiting osteoclastogenesis. AVI, CIA, RA
38  2019 Atg5 Supports Rickettsia australis Infection in Macrophages In Vitro and In Vivo. IL-1beta, LC3
39  2019 Autophagy exerts pivotal roles in regulatory effects of 1alpha,25-(OH)2D3 on the osteoclastogenesis. OCPs
40  2019 Autophagy mediated by JNK1 resists apoptosis through TRAF3 degradation in osteoclastogenesis. OCPs
41  2019 Berberine coated mannosylated liposomes curtail RANKL stimulated osteoclastogenesis through the modulation of GSK3beta pathway via upregulating miR-23a. ---
42  2019 Berberine Suppresses RANKL-Induced Osteoclast Differentiation by Inhibiting c-Fos and NFATc1 Expression. BBR, LPS, NFATc1, OSCAR, RANKL
43  2019 Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells. C3ar1, HSCs
44  2019 Cholera toxin B induces interleukin-1beta production from resident peritoneal macrophages through the pyrin inflammasome as well as the NLRP3 inflammasome. CTB, IL-1beta, PKA
45  2019 Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis. IRF, NFATc1, OC, RANKL
46  2019 Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-beta Signaling. CDNs, IFN, IFNAR, M-CSF, RANKL
47  2019 Cyclin-dependent kinase 8/19 inhibition suppresses osteoclastogenesis by downregulating RANK and promotes osteoblast mineralization and cancellous bone healing. CDK8, DC-STAMP, NF-kappaB, NFATc1, TRAP
48  2019 Effects of adiponectin on osteoclastogenesis from mouse bone marrow-derived monocytes. M-CSF, RANKL, TRAP
49  2019 EPC-derived exosomes promote osteoclastogenesis through LncRNA-MALAT1. EPCs
50  2019 Estrogen-related receptor gamma negatively regulates osteoclastogenesis and protects against inflammatory bone loss. ERRgamma, NF-kappaB, RANKL
51  2019 Extracts of Flavoparmelia sp. Inhibit Receptor Activator of Nuclear Factor-kappaB Ligand-Mediated Osteoclast Differentiation. RANKL
52  2019 Fermented Oyster Extract Prevents Ovariectomy-Induced Bone Loss and Suppresses Osteoclastogenesis. RANKL
53  2019 Generation of Bone Marrow-Derived Macrophages for InVitro Infection Experiments. CSF-1
54  2019 Gentiopicroside (GENT) protects against sepsis induced by lipopolysaccharide (LPS) through the NF-kappaB signaling pathway. ELISA, Gent, IFN, IL, LPS, PEMs, qPCR, TNF
55  2019 GRK2 Mediated Abnormal Transduction of PGE2-EP4-cAMP-CREB Signaling Induces the Imbalance of Macrophages Polarization in Collagen-Induced Arthritis Mice. cAMP, CIA, CREB, GRK2, PGE2, PMs, RA
56  2019 Homer2 and Homer3 modulate RANKL-induced NFATc1 signaling in osteoclastogenesis and bone metabolism. NFATc1, RANKL
57  2019 Influence of radiation exposure pattern on the bone injury and osteoclastogenesis in a rat model. MAR
58  2019 InP/ZnS Quantum Dots Cause Inflammatory Response in Macrophages Through Endoplasmic Reticulum Stress and Oxidative stress. ELISA, ER, IL-6, PEG, QDs
59  2019 Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-kappaB and NFATc1. CTSK, IL, IL-28Ralpha, MMP-9, NF-kappaB, NFATc1, PBMCs, RANKL, TRAP
60  2019 Licorice isoliquiritigenin-encapsulated mesoporous silica nanoparticles for osteoclast inhibition and bone loss prevention. AP, IkappaBalpha, ISL, LPS, MAPKs, MSNs, NF-kappaB, RANKL, TRAF6
61  2019 Lipoteichoic acid of Enterococcus faecalis inhibits osteoclastogenesis via transcription factor RBP-J. LTA
62  2019 MicroRNA-1225 activates Keap1-Nrf2-HO-1 signalling to inhibit TNFalpha-induced osteoclastogenesis by mediating ROS generation. miR-1225, RANKL, ROS, TNF, TRAP
63  2019 MicroRNA-506 upregulation contributes to sirtuin 1 inhibition of osteoclastogenesis in bone marrow stromal cells induced by TNF-alpha treatment. ROS, SIRT1
64  2019 Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3beta/NFATc1 signalling pathway. MACF1, RANKL
65  2019 miR-101-3p/Rap1b signal pathway plays a key role in osteoclast differentiation after treatment with bisphosphonates. ---
66  2019 miR-142-5p promotes the osteoclast differentiation of bone marrow-derived macrophages via PTEN/PI3K/AKT/FoxO1 pathway. miRNAs
67  2019 Mitofusin 2, a mitochondria-ER tethering protein, facilitates osteoclastogenesis by regulating the calcium-calcineurin-NFATc1 axis. Mfn2, RANKL
68  2019 Nobiletin-loaded micelles reduce ovariectomy-induced bone loss by suppressing osteoclastogenesis. NOB, NOB-PEG-PCL, TRAP
69  2019 Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic. Nrf2, ROS
70  2019 Pentamidine Inhibits Titanium Particle-Induced Osteolysis In Vivo and Receptor Activator of Nuclear Factor-kappaB Ligand-Mediated Osteoclast Differentiation In Vitro. RANKL, Ti
71  2019 PIP5k1beta controls bone homeostasis through modulating both osteoclast and osteoblast differentiation. ---
72  2019 PSTP-3,5-Me Inhibits Osteoclast Differentiation and Bone Resorption. CTSK, M-CSF, NFATc1, PSTP, RANKL, TRAP
73  2019 Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and -independent autophagic responses. CCK-8, EdU, OCPs, TRAP
74  2019 RANKL-induced osteoclastogenesis in bone marrow-derived macrophages is suppressed by cisapride. 5-HT, ALP, RANKL, TRAP
75  2019 Reversal of Osteoporotic Activity by Endothelial Cell-Secreted Bone Targeting and Biocompatible Exosomes. EC
76  2019 Semaphorin 3A gets involved in the establishment of mouse tootheruptive pathway. Sema 3A
77  2019 SIRT2 deficiency prevents age-related bone loss in rats by inhibiting osteoclastogenesis. HDACs, SIRT2, Tb.N
78  2019 Sirtuin 1 inhibits TNF-alpha-mediated osteoclastogenesis of bone marrow-derived macrophages through both ROS generation and TRPV1 activation. ROS, SIRT1, TNF, TRPV1
79  2019 Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation. ---
80  2019 Targeting vascular endothelial growth factor ameliorates PMMA-particles induced inflammatory osteolysis in murine calvaria. PMMA, TNF, VEGF, vWF
81  2019 Taxifolin Inhibits Receptor Activator of NF-kappaB Ligand-Induced Osteoclastogenesis of Human Bone Marrow-Derived Macrophages in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo. RANKL
82  2019 The effects of trehalose glycolipid presentation on cytokine production by GM-CSF macrophages. TGLs
83  2019 The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor alpha. HCS, TNF-alpha
84  2019 The use of apocynin inhibits osteoclastogenesis. APO, NAC, NOX, ROS, TRAP
85  2019 Water Extracts of Hull-less Waxy Barley (Hordeum vulgare L.) Cultivar 'Boseokchal' Inhibit RANKL-induced Osteoclastogenesis. ---
86  2018 A flavonoids compound inhibits osteoclast differentiation by attenuating RANKL induced NFATc-1/c-Fos induction. MAPKs, NFATc-1, RANKL, STAT3, TFs
87  2018 A prenylated flavonoid, 10-oxomornigrol F, exhibits anti-inflammatory effects by activating the Nrf2/heme oxygenase-1 pathway in macrophage cells. COX-2, HO, IL, iNOS, LPS, MAPK, NAC, NO, NQO1, Nrf2, OMF, ROS, TNF-alpha
88  2018 Activation of NLRP3 inflammasome in macrophages by mycoplasmal lipoproteins and lipopeptides. IL-1beta, NLRP3, TLR2
89  2018 Anti-Osteoporotic Effects of Polysaccharides Isolated from Persimmon Leaves via Osteoclastogenesis Inhibition. MAPKs, NFATc1, RANKL
90  2018 Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo. ART, LPS
91  2018 Aryl hydrocarbon receptor activation by benzo(a)pyrene inhibits proliferation of myeloid precursor cells and alters the differentiation state as well as the functional phenotype of murine bone marrow-derived macrophages. AhR, BaP, BMCs, CXCL1, HK, IL, MHC-II, NO, TNF
92  2018 Benzo(a)pyrene attenuates the pattern-recognition-receptor induced proinflammatory phenotype of murine macrophages by inducing IL-10 expression in an aryl hydrocarbon receptor-dependent manner. AhR, BaP, IL, MHC-II, NO, PAMPs, PRRs, TNF
93  2018 Berberine inhibits IL-21/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the attenuation of PI3K/Akt signaling pathway and ameliorates IL-21 mediated osteoclastogenesis. AA-FLS, BBR, IL-1beta, IL-23, IL-6, MMP9, mTOR, NF-kappaB, NFATc1, PTEN, TNF-alpha, TRAP
94  2018 Crocin inhibits RANKL‑induced osteoclastogenesis by regulating JNK and NF‑kappaB signaling pathways. RANKL
95  2018 Cryptotanshinone inhibits RANKL-induced osteoclastogenesis by regulating ERK and NF-kappaB signaling pathways. CTS, NFAT, OS, RANKL, TRAP
96  2018 Cysteinyl leukotriene receptor 1 (cysLT1R) regulates osteoclast differentiation and bone resorption. cysLT1R
97  2018 Daphnetin inhibits RANKL-induced osteoclastogenesis in vitro. RANKL, ROS
98  2018 Data on the expression of CXCR3 ligands and pro-inflammatory cytokines in macrophages and CD4+ T cells after stimuli of CXCR3 ligands. CXCR3
99  2018 Effect of remifentanil on pre-osteoclast cell differentiation in vitro. pre-OCs
100  2018 Effects of Melatonin and Its Underlying Mechanism on Ethanol-Stimulated Senescence and Osteoclastic Differentiation in Human Periodontal Ligament Cells and Cementoblasts. AMPK, EtOH, hPDLCs, IL, MAPK, mTOR, NFAT, PIN1, ROS, SASP